Takai Ali Bayas Ali
About Takai Ali Bayas Ali
Data last updated:
Takai Ali Bayas Ali is a Director at Maxell Pharma Private Limited (since 2010) and Director at Mastro Biologicals Private Limited (since 2021). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹13.21 Cr; the largest is Maxell Pharma Private Limited at ₹6.92 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maxell Pharma Private Limited U24297TN2010PTC075380 | Director | 16 Apr 2010 | 2010 | ₹6.92 Cr (FY 2024) | Active |
| Mastro Biologicals Private Limited U24230TN2021PTC143513 | Director | 15 May 2021 | 2021 | ₹6.30 Cr (FY 2025) | Active |
Board colleagues of Takai Ali Bayas Ali
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gnanasekaran Satheeshkumar | 02972414 | Maxell Pharma Private Limited | Director |
| Madhuram Senthil Kumar | 09066311 | Maxell Pharma Private Limited | Director |
| Madhuram Udhaya Chander | 02997703 | Maxell Pharma Private Limited | Director |
| Saravanan | 02972417 | Maxell Pharma Private Limited | Director |
| Shankar Subramanian | 03015878 | Maxell Pharma Private Limited | Managing Director |
| Bayasali Kumail Hasan | 10420342 | Mastro Biologicals Private Limited | Director |
| Mohammadi Naveen Taj | 09174716 | Mastro Biologicals Private Limited | Director |
| Mohammadzuber Abubakar Kaldar | 09174715 | Mastro Biologicals Private Limited | Director |
| Niyamathullah Jamir Ahmed | 01769286 | Mastro Biologicals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Takai Ali Bayas Ali
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Takai Ali Bayas Ali
Takai Ali Bayas Ali currently holds 2 directorships: Maxell Pharma Private Limited (Director, since 16 Apr 2010, revenue ₹6.92 Cr (FY 2024)); Mastro Biologicals Private Limited (Director, since 15 May 2021, revenue ₹6.30 Cr (FY 2025)).
Takai Ali Bayas Ali was first appointed on 16 Apr 2010 as Director at Maxell Pharma Private Limited. The most recent appointment on record is 15 May 2021 at Mastro Biologicals Private Limited.
The 2 current companies of Takai Ali Bayas Ali that report revenue have a combined latest revenue of ₹13.21 Cr: Maxell Pharma Private Limited ₹6.92 Cr (FY 2024); Mastro Biologicals Private Limited ₹6.30 Cr (FY 2025).
The current boards of Takai Ali Bayas Ali's companies include Gnanasekaran Satheeshkumar (Maxell Pharma Private Limited), Madhuram Senthil Kumar (Maxell Pharma Private Limited), Madhuram Udhaya Chander (Maxell Pharma Private Limited), Saravanan (Maxell Pharma Private Limited), Shankar Subramanian (Maxell Pharma Private Limited), Bayasali Kumail Hasan (Mastro Biologicals Private Limited), among others.